Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Nine more pharma groups have agreed to lower the costs of their medicines in the US under the Trump administration's most favoured nation (MFN) scheme in return for avoiding tariffs. US companies ...
Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator ...
Stacker on MSNOpinion
Common medications for high cholesterol
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
Zacks.com on MSN
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
From a price-performance perspective, BMY has fetched slightly better returns than AMGN in the past six months. Shares of ...
Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...
MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...
Verywell Health on MSN
Wegovy Now Comes in a Pill. Here’s How It Compares to the Injection
Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.
Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients ...
The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...
Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results